Hyperliquid Strategies, a Nasdaq-listed company using equity sales to build a treasury of Hyperliquid’s HYPE token, has expanded its committed-equity facility with Chardan Capital Markets to $2.5 billion from $1 billion.
The immediate runway before a new dilution constraint applies is far smaller than the headline commitment. Hyperliquid Strategies’ annual report disclosed $646.6 million of gross facility proceeds through June 30, followed by another $117.1 million raised through facility shares after quarter-end. Together, those figures show at least $763.7 million of proceeds, leaving no more than about $236.3 million before aggregate sales reach $1 billion. Any later sales would reduce that headroom, and the September 1 filing did not provide an updated utilization total.
Once aggregate facility sales pass $1 billion, the issue price becomes decisive. Under the operative amendment, Hyperliquid Strategies cannot complete a sale if doing so would take the aggregate number of facility shares issued at prices below $12.02 above 42,641,847. That exchange cap equals 19.99% of the company’s pre-amendment voting power or outstanding common shares. Issuance above the cap requires stockholder approval unless that approval is not required under Nasdaq rules.
The restriction does not, however, translate into a clean dollar ceiling. Shares sold at $12.02 or more do not fall under the price-specific cap, while the remaining capacity for lower-priced sales depends on how many qualifying shares already count toward it. The filings disclose aggregate shares, proceeds and an average price, but not the transaction-level price mix needed to calculate that count. The amendment also permits the cap to be reduced by other transactions that Nasdaq treats as part of the same issuance.
The dilution mechanism matters because equity sales have financed the company’s crypto treasury strategy. An August 27 update said Hyperliquid Strategies had deployed $773.4 million to acquire about 16.5 million HYPE and held roughly 29.3 million HYPE in total. It also reported $646.6 million raised at an average issue price of $8.70; that figure did not include the additional $117.1 million of post-June 30 facility sales disclosed in the annual report.
The $2.5 billion facility therefore represents optional financing capacity, not a guaranteed HYPE buying program. The dated disclosures indicate at most $236.3 million remained before the $1 billion trigger; beyond that point, access to the full commitment will depend on sale prices, remaining exchange-cap headroom and whether stockholders must authorize additional discounted issuance.